Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in CIPN

News   Dec 10, 2012

 
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in CIPN
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT